Finance

Lists
Why is 002720 down 3,39%?
Dive Deeper
002720:KRX
Kukje Pharma Co Ltd
3 985,00 KRW
-3,39%
(-140,00) 1D
19-окт., 15:30:21 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 002720...
Open
4 100 KRW
High
4 200 KRW
Low
3 850 KRW
Mkt. cap
84,32 млд
Avg. vol.
3,47 млн
Volume
1,99 млн
Dividend
0,75%
Quarterly dividend
8 KRW
Ex-dividend date
2026-ж., 12-мар.
P/E ratio
16,70
52-wk high
5 470 KRW
52-wk low
2 810 KRW
EPS
239 KRW
Shares outstanding
21,16 млн
No. of employees
267
Open
4 100 KRW
High
4 200 KRW
Low
3 850 KRW
Mkt. cap
84,32 млд
Avg. vol.
3,47 млн
Volume
1,99 млн
Dividend
0,75%
Quarterly dividend
8 KRW
Ex-dividend date
2026-ж., 12-мар.
P/E ratio
16,70
52-wk high
5 470 KRW
52-wk low
2 810 KRW
EPS
239 KRW
Shares outstanding
21,16 млн
No. of employees
267
News stories
From web sources and news partners
About Kukje Pharma Co Ltd
CEO-
Employees267
Founded1959
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
45,63 млд
43,34 млд
43,98 млд
48,32 млд
Cost of goods sold
20,70 млд
21,74 млд
20,17 млд
21,41 млд
Cost of revenue
20,70 млд
21,74 млд
20,17 млд
21,41 млд
Research and development expenses
658,59 млн
1,79 млд
931,78 млн
1,34 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,13 млд
21,36 млд
20,66 млд
23,05 млд
Operating expense
23,02 млд
23,14 млд
21,85 млд
24,77 млд
Total operating expenses
43,72 млд
44,88 млд
42,01 млд
46,18 млд
Operating income
1,92 млд
-1,54 млд
1,97 млд
2,13 млд
Other non operating income
392,85 млн
195,68 млн
199,95 млн
268,92 млн
EBT including unusual items
2,42 млд
-1,54 млд
2,62 млд
2,18 млд
EBT excluding unusual items
2,41 млд
-1,34 млд
2,60 млд
2,23 млд
Income tax expense
505,72 млн
-808,40 млн
477,03 млн
513,17 млн
Effective tax rate
20,87%
52,36%
18,20%
23,54%
Other operating expenses
-
-
-
-
Net income
1,91 млд
-731,53 млн
2,15 млд
1,67 млд
Net profit margin
4,19%
-1,69%
4,88%
3,46%
Earnings per share
-
-
-
-
Interest and investment income
139,49 млн
130,84 млн
77,28 млн
83,58 млн
Interest expense
-218,61 млн
-198,95 млн
-188,96 млн
-195,74 млн
Net interest expenses
-79,12 млн
-68,10 млн
-111,69 млн
-112,16 млн
Depreciation and amortization charges
167,22 млн
161,54 млн
168,12 млн
197,45 млн
EBITDA
2,73 млд
-723,71 млн
2,81 млд
3,02 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору